XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements

The following tables summarize the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):

 

 

 

 

 

June 30, 2022

 

 

 

Valuation
Hierarchy

 

Amortized
Costs

 

 

Gross
Unrealized
Holding
Gains

 

 

Gross
Unrealized
Holding
Losses

 

 

Aggregate
Fair Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

31,353

 

 

$

 

 

$

 

 

$

31,353

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

Level 1

 

 

76,950

 

 

 

 

 

 

(518

)

 

 

76,432

 

Corporate debt

 

Level 2

 

 

78,645

 

 

 

 

 

 

(437

)

 

 

78,208

 

Commercial paper

 

Level 2

 

 

31,925

 

 

 

 

 

 

 

 

 

31,925

 

Total cash equivalents and
   short-term investments

 

 

 

$

218,873

 

 

$

 

 

$

(955

)

 

$

217,918

 

 

 

 

 

 

December 31, 2021

 

 

 

Valuation
Hierarchy

 

Amortized
Costs

 

 

Gross
Unrealized
Holding
Gains

 

 

Gross
Unrealized
Holding
Losses

 

 

Aggregate
Fair Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

60,844

 

 

$

 

 

$

 

 

$

60,844

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

Level 1

 

 

18,064

 

 

 

 

 

 

(60

)

 

 

18,004

 

Corporate debt

 

Level 2

 

 

124,178

 

 

 

2

 

 

 

(125

)

 

 

124,055

 

Commercial paper

 

Level 2

 

 

15,081

 

 

 

 

 

 

 

 

 

15,081

 

Total cash equivalents and
   short-term investments

 

 

 

$

218,167

 

 

$

2

 

 

$

(185

)

 

$

217,984

 

 

As of June 30, 2022, the remaining contractual maturities for available-for-sale securities were one month to thirteen months.

Impairment assessments are made at the individual security level at each reporting period. When the fair value of an available-for-sale security is less than its cost at the balance sheet date, a determination is made as to whether the impairment is other-than-temporary and, if it is other-than-temporary, an impairment loss is recognized in earnings equal to the difference between the investment’s amortized cost and fair value at such date. As of June 30, 2022, there were three securities with a total fair value of $18.0 million in an unrealized loss position for more than 12 months. The unrealized losses totaling $89,000 as of June 30, 2022 were caused by changes in market interest rates or the widening of market spreads subsequent to the initial purchase of these securities, and not related to the underlying credit of the issuers or the underlying collateral. These securities were issued by public reporting companies with an investment-grade rating by at least one bond credit rating agency. As a result, the Company did not consider these investments to be other-than-temporarily impaired as of June 30, 2022. During the three and six months ended June 30, 2022 and 2021, the Company did not recognize other-than-temporary impairment losses related to its investment securities.